Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A data mining approach for signal detection and analysis.

Andrew Bate1, Marie Lindquist, I Ralph Edwards

  • 1The Uppsala Monitoring Centre, WHO Collaborating Centre for International Drug Monitoring, Uppsala, Sweden. andrew.bate@who-umc.org

Drug Safety
|June 20, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Global Perspective on the Evolution and Future of Pharmacovigilance: Deliverables from the 24th Annual Meeting of the International Society of Pharmacovigilance Celebrating 25 Years of Excellence.

Drug safety·2026
Same author

Reply to "A Comment about AI Methods that May Help Advance Pharmacovigilance".

Clinical pharmacology and therapeutics·2026
Same author

9<sup>th</sup> ISoP Intelligent Automation Boston Seminar: From Innovation to Impact. Building Trustworthy AI in Pharmacovigilance 4-5 December 2025 | Cambridge, USA & Virtual.

Drug safety·2026
Same author

Ontology-based Semantic Similarity Measures for Clustering Medical Concepts in Drug Safety.

AMIA ... Annual Symposium proceedings. AMIA Symposium·2026
Same author

PVLens: Enhancing Pharmacovigilance Through Automated Label Extraction.

AMIA ... Annual Symposium proceedings. AMIA Symposium·2026
Same author

Performance of the Self-Controlled Case Series for Drug Safety Signal Detection: A Multi-Database Study.

Pharmacoepidemiology and drug safety·2026
Same journal

Availability and Communication of Risk Management Strategies for Pregnancy Category X Medicines across Australian Medicine Information Sources.

Drug safety·2026
Same journal

The Bidirectionality of Lawyer Reporting Bias in Disproportionality Analysis.

Drug safety·2026
Same journal

Safety of Biologic and Targeted Synthetic Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis: A Longitudinal Analysis.

Drug safety·2026
Same journal

Developing a Hierarchical Algorithm to Identify Pregnancies and Determine Gestational Age from Nationwide Linked Health Data in Taiwan.

Drug safety·2026
Same journal

Safety and Effectiveness of Direct Oral Anticoagulants Versus Low-Molecular-Weight Heparin for Cancer-Associated Thrombosis: A Systematic Review and Meta-analysis.

Drug safety·2026
Same journal

Analytic Misjudgment of Drug Safety Evidence and Causality: From the Prosecutor's Fallacy and Simpson's Paradox to Artificial Intelligence.

Drug safety·2026
See all related articles

The Bayesian confidence propagation neural network (BCPNN) method analyzes WHO drug safety data to detect adverse reaction signals. This quantitative approach identifies unexpected drug associations for clinical assessment.

Area of Science:

  • Pharmacovigilance
  • Computational Statistics
  • Drug Safety

Background:

  • The World Health Organization (WHO) database contains over 2.5 million case reports on adverse drug reactions.
  • Effective signal detection from this large dataset is crucial for public health.
  • Existing methods require enhancement for comprehensive analysis of complex drug interactions.

Purpose of the Study:

  • To present an overview of a quantitative method for signal detection in the WHO adverse drug reaction database.
  • To highlight dependencies and unexpected relationships within the drug adverse reaction data.
  • To demonstrate the application of the Bayesian confidence propagation neural network (BCPNN) for drug safety analysis.

Main Methods:

  • Utilizing the Bayesian confidence propagation neural network (BCPNN) for analyzing drug adverse reaction combinations.

Related Experiment Videos

  • Implementing Bayesian statistics within a neural network architecture.
  • Extending the approach to identify drug group effects and higher-order dependencies.

    • Main Results:

    • The BCPNN method is now in routine use for drug adverse reaction signal detection.
    • Quantitatively strong and unexpected relationships in the data were highlighted.
    • Identified associations were found to be significant relative to general reporting frequencies.

    Conclusions:

    • The BCPNN method effectively identifies potential drug safety signals from large-scale pharmacovigilance data.
    • This quantitative approach aids in the clinical assessment of suspected adverse drug effects.
    • The method's extension to higher-order dependencies offers deeper insights into drug interactions.